Boston Scientific Restructuring Charges increased by 300.0% to $16.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 300.0%, from $4.00M to $16.00M. Over 4 years (FY 2021 to FY 2025), Restructuring Charges shows an upward trend with a 26.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Frequent or large charges may indicate operational instability or a need for significant strategic pivots, while occasional charges are standard in large-scale transformations.
Restructuring charges are one-time costs associated with reorganizing a company's operations, such as severance pay, fac...
Used by analysts to identify non-recurring items that distort year-over-year operating comparisons.
is_restructuring_charges| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $9.00M | $23.00M | $4.00M | $11.00M | $4.00M | $5.00M | $20.00M | $16.00M | $15.00M | $18.00M | $3.00M | $1.00M | $8.00M | $4.00M | $10.00M | $83.00M | -$8.00M | $16.00M |
| QoQ Change | — | +200.0% | +155.6% | -82.6% | +175.0% | -63.6% | +25.0% | +300.0% | -20.0% | -6.3% | +20.0% | -83.3% | -66.7% | +700.0% | -50.0% | +150.0% | +730.0% | -109.6% | +300.0% |
| YoY Change | — | — | — | — | +266.7% | -55.6% | -78.3% | +400.0% | +45.5% | +275.0% | +260.0% | -85.0% | -93.8% | -46.7% | -77.8% | +233.3% | >999% | -200.0% | +300.0% |